Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 22, 2012 | Anaphore Buys Chinese Firm, Gains $15M In Funding | La Jolla-based Anaphore, a startup biopharmaceuticals developer, said today that it has acquired a Chinese firm, RuiYi Inc., and closed on the second tranche of its Series A financing, worth $15M. Anaphore said it acquired RuiYi to gain acc... |
| With a band of biotech collaborators, RuiYi sets sail developing new biologic drugs for China | The La Jolla, California, biotech formerly known as Anaphore is looking a little different these days. Under the leadership of former Fate Therapeutics CEO Paul Grayson, Anaphore changed its name to RuiYi Inc., honed its focus from developi... |
Reviews 0
FAQ about Anaphore
What has the press written about Anaphore?
Parsers VC has collected 3 articles mentioning Anaphore, among them “Anaphore Buys Chinese Firm, Gains $15M In Funding” (Mar 22, 2012) and “With a band of biotech collaborators, RuiYi sets sail developing new biologic drugs for China”.
Is Anaphore still active?
Anaphore is probably closed: its latest activity on Parsers VC dates from May 16, 2013.